JUST IN　•　MarketWatch.com - Top Stories

Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.

SHARE THIS STORYPLUS UNLOCKS FAVORITES READ LATER AND SOURCE CONTROL

The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.

READ ORIGINAL REPORT ↗

THIS JUST HAPPENED PACKAGES THE WORLD INTO A FAST LIVE FEED SOURCE REPORTING STAYS ONE CLICK AWAY

RELATED POSTSMORE FINANCE

FINANCE　•　MarketWatch.com - Top Stories

ServiceNow’s stock is on track for its worst day ever. Here’s what went wrong.

FINANCE　•　MarketWatch.com - Top Stories

Economy grows at fastest pace in a year, GDP shows — and shows little sign of slowing

FINANCE　•　MarketWatch.com - Top Stories

Why Alphabet’s stock could see its worst day ever after the latest results

FINANCE　•　CBC | Top Stories News

Financial intelligence agency slow to provide police with info to curb money laundering: AG

FINANCE　•　The Latest News from the UK and Around the World | Sky News

Will she stand? Lagarde quits European Central Bank ahead of French election

FINANCE　•　The Latest News from the UK and Around the World | Sky News

Profits up billions at both UK's biggest mortgage provider and major oil producer

FINANCE　•　CBC | Top Stories News

He tried to get into Montreal's kosher market. It led to a battle over alleged meat monopoly

FINANCE　•　Ars Technica - All content

Trump admin sues Utah to save Kalshi from the state's total ban on gambling